Sign in
Diabetic Retinopathy Take Home Panel
Annual Meeting Talks
2020
Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER Trials
Carl D. Regillo, MD
2019
Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
Category: AMD-Neovascular